RAC Medical Devices Practice Exam 2026 – Comprehensive Test Prep

A 510(k) submission is a regulatory pathway used by manufacturers to demonstrate that a new medical device is substantially equivalent to an existing, legally marketed predicate device. This process is outlined in the Federal Food, Drug, and Cosmetic Act and is crucial for obtaining clearance from the U.S. Food and Drug Administration (FDA) before marketing the device.

The concept of "substantial equivalence" means that the new device has the same intended use and is similar in design, performance, and safety to a predicate device that is already on the market. A successful 510(k) submission allows manufacturers to avoid the more involved and lengthy premarket approval (PMA) process that applies to devices that are not deemed to be substantially equivalent.

The other options do not accurately reflect the purpose of a 510(k) submission: it does not specifically demonstrate approval for human trials, nor does it imply that the device is entirely new without a comparison point. Additionally, it does not indicate that the device has completed all clinical evaluations, as the 510(k) process does not necessarily require such extensive clinical data unless it involves decisions about equivalence. Thus, the focus on substantial equivalence in option B captures the essence of what a 510(k) submission entails.